Thursday, September 16, 2021
Virpax Pharmaceuticals (NASDAQ: VRPX) Shares Jump After FDA Provides Pre-IND Response and Guidance to MMS019
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) is a biopharmaceutical company that is focused on the research and development of treatment candidates...
Read more
Arcturus Therapeutics Holdings, Inc. (NASDAQ: ARCT) Receives Approval for Singapore Clinical Trial of Next-Gen mRNA Vaccines for COVID Variants
Arcturus Therapeutics Holdings, Inc. (NASDAQ: ARCT) is a San Diego-based, clinical-stage mRNA medicine and vaccine company, which is focusing on...
Read more
ImmunoPrecise Antibodies, Ltd. (NASDAQ: IPA) Shares More Than Double After Antibody Cocktail Shows Potential Ability to Neutralize COVID Delta Variant
ImmunoPrecise Antibodies, Ltd. (NASDAQ: IPA) is engaged as an innovative technology company, which is designed to research and develop novel...
Read more
NeuroMetrix, Inc. (NASDAQ: NURO) Shares Skyrocket After its Wearable Treatment for Fibromyalgia Receives FDA Breakthrough Device Designation
NeuroMetrix, Inc. (NASDAQ: NURO) is engaged as a medical technology and device company, which is focused on the research, development,...
Read more
Cytokinetics, Inc. (NASDAQ: CYTK) Shares Rally After Strong Clinical Results From Its Heart Disease Treatment Candidate
Cytokinetics, Inc. (NASDAQ: CYTK) is engaged as a late-stage biopharmaceutical company, which is focused on the research, development, and commercialization...
Read more
Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) Skyrockets 93% After CVL-231 Phase 1b Clinical Trial Reports Positive Topline Results for Schizophrenia Treatment
Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) is a Cambridge, Massachusetts-based biotechnology company that is focused on the research and development...
Read more
Kindred Biosciences, Inc. (NASDAQ: KIN) Surges 46% After Entering into an Agreement to be Acquired By Elanco Animal Health, Inc. (NYSE: ELAN)
Kindred Biosciences, Inc. (NASDAQ: KIN) is a biopharmaceutical company, which is focused on the research and development of innovative therapies...
Read more
Enochian Biosciences, Inc. (NASDAQ: ENOB) Jumps 107% After FDA Accepts Pre-IND Request for its Potential HIV Break-Through Treatment
Enochian Biosciences, Inc. (NASDAQ: ENOB) is engaged as a biopharmaceutical company, which is focused on the research, development, manufacturing, and...
Read more
Trxade Group, Inc. (NASDAQ: MEDS) Soars 147% After Launching its MedCheks Health Passport App
Trxade Group, Inc. (NASDAQ: MEDS) is engaged as a health services IT company, which is specifically focused on the digitalization...
Read more
Adhera Therapeutics, Inc. (OTC Pink: ATRX) Skyrockets 272% After Signing LOI to Acquire a New Drug Class Aimed at Fighting Parkinson’s Disease
Adhera Therapeutics, Inc. (OTC Pink: ATRX) is a clinical stage biopharmaceutical company that is focused on acquiring and developing advanced...
Read more
